United Therapeutics (UTHR) Form 144 Discloses Recent Insider Sales

Rhea-AI Filing Summary

Form 144 filed for United Therapeutics (UTHR) reporting proposed and recent insider sales by Martine Rothblatt. The notice lists a proposed sale of 4,000 common shares through TD Securities on 09/24/2025 with an aggregate market value of $1,736,408.50 and shows the company has 45,230,000 shares outstanding. The filer records the original acquisition of the securities on 03/15/2016 under an executive deferred compensation arrangement, noting 294,000 shares acquired and that payment involved exercised options and common shares. The filing also discloses multiple sales by Martine Rothblatt from 09/09/2025 through 09/23/2025 totaling 48,000 common shares with gross proceeds listed per trade.

Positive

• Clear disclosure of proposed sale date, broker, and aggregate market value for the 4,000-share transaction
• Complete acquisition history provided (acquired 03/15/2016 under executive deferred compensation) and payment method noted

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider disposition disclosed; transaction sizes are clear but not material to share count.

The filing documents a proposed sale of 4,000 shares and prior open-market sales totaling 48,000 shares by Martine Rothblatt. Compared with the 45.23 million shares outstanding, these transactions represent a small percentage of float and are typical of scheduled executive share dispositions or compensation-related monetization. The notice properly discloses acquisition source and payment method, helping market transparency. No earnings or operational metrics are included, so market impact is likely limited absent other news.

Compliance / Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure requirements and documents trading history and acquisition facts.

The form provides required details: broker, planned sale date, aggregate market value, acquisition date and nature, and recent sales history. The signature/attestation language is included, indicating the filer affirms no undisclosed material nonpublic information. From a governance standpoint this is a standard disclosure supporting compliance with resale rules; it allows investors to verify insider activity and adherence to trading protocols.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	TD SECURITIES (USA) LLC 125 PARK AVE, 20TH FLOOR NEW YORK NY 10017	4000	1736408.50	45230000	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/15/2016	EXECUTIVE DEFERRED COMPENSATION	MARTINE ROTHBLATT			294000	03/15/2016	SHARES EXERCISED VIA VESTED OPTIONS AND PAYMENT MADE VIA COMMON SHARES

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/09/2025	8000	3188374.33
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/10/2025	4000	1594872.82
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/11/2025	4000	1588904.00
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/12/2025	4000	1615897.79
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/15/2025	4000	1591535.70
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/16/2025	4000	1601062.04
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/17/2025	4000	1600686.85
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/18/2025	4000	1617665.13
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/19/2025	4000	1644310.00
MARTINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/22/2025	4000	1669212.50
MARRINE ROTHBLATT 1000 SPRING STREET SILVER SPRING MD 20910	COMMON	09/23/2025	4000	1672512.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 from UTHR disclose about planned sales?

The form discloses a proposed sale of 4,000 common shares through TD Securities on 09/24/2025 with aggregate market value of $1,736,408.50.

Who is the seller named in the filing for UTHR?

The seller is Martine Rothblatt, listed as the person for whose account the securities are to be sold.

How many shares were sold by the insider in the past three months per the filing?

The filing lists sales from 09/09/2025 through 09/23/2025 totaling 48,000 common shares with gross proceeds shown for each trade.

When and how were the acquired shares originally obtained?

The securities were acquired on 03/15/2016 via an executive deferred compensation arrangement; payment involved shares exercised via vested options and common shares.

How large are these sales relative to UTHR's outstanding shares?

The filing shows 45,230,000 shares outstanding; the disclosed recent sales (48,000 shares) and proposed 4,000-share sale are a small fraction of outstanding shares.